Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1997-8-5
pubmed:abstractText
In patients with chronic hepatitis C, determination of hepatitis C virus (HCV) genotype could be routinely run in the future to tailor treatment schedules. The suitabilities of two versions of a serological, so-called serotyping assay (Murex HCV Serotyping Assay version 1-3 [SA1-3] and Murex HCV Serotyping Assay version 1-6 [SA1-6]; Murex Diagnostics Ltd.), based on the detection of genotype-specific antibodies directed to epitopes encoded by the NS4 region of the genome, for the routine determination of HCV genotypes were studied. The results were compared with those of a molecular biology-based genotyping method (HCV Line Probe Assay [INNO-LiPA HCV]; Innogenetics S.A.), based on hybridization of PCR products onto genotype-specific probes designed in the 5' noncoding region of the genome, obtained with pretreatment serum samples from 88 patients with chronic hepatitis C eligible for interferon therapy. Definitive genotyping was performed by sequence analysis of three regions of the viral genome in all samples with discrepant typing results found among at least two of the three assays studied. In all instances, sequence analysis confirmed the result of the INNO-LiPA HCV test. The sensitivity of SA1-3 was 75% relative to the results obtained by the genotyping assay. The results were concordant with those of genotyping for 92% of the samples typeable by SA1-3. The sensitivity of SA1-6 was 89% relative to the results obtained by the genotyping assay. The results were concordant with those of genotyping for 94% of the samples typeable by SA1-6. Overall, SA1-6 had increased sensitivity relative to SA1-3 but remained less sensitive than the genotyping assay on the basis of PCR amplification of HCV RNA. Cross-reactivities between different HCV genotypes could be responsible for the mistyping of 8 (SA1-3) and 6% (SA1-6) of the samples. Subtyping of 1a and 1b is still not possible with the existing peptides, but discriminating between subtypes may not be necessary for routine use.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-1312125, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7514558, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7524083, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7542272, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7595353, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7678473, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7678709, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7686182, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7698576, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7730804, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7769300, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7810932, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7814491, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7844363, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7927243, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-7982639, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8058787, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8245854, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8389799, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8576357, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8578855, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8621170, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-8655978, http://linkedlifedata.com/resource/pubmed/commentcorrection/9196183-9049379
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1734-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay.
pubmed:affiliation
Department of Bacteriology and Virology, Hôpital Henri Mondor, Université Paris XII, Créteil, France. pawlotsky@univ-paris12.fr
pubmed:publicationType
Journal Article